Immune Regulation Funding: $53M Raised, Series B (2020)
Immune Regulation is based in Boston, MA. It has raised $53M in total funding. Latest round: Series B.
Immune Regulation funding overview
Immune Regulation is based in Boston, MA. Immune Regulation has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2020. The round record for Immune Regulation runs through 2020; nothing later has been disclosed. Investors on record include Morningside Ventures, 24Haymarket, Metellus AG. 3 distinct backers are named across the disclosed rounds.
Immune Regulation at a glance
Total raised
$53M
Latest round
Series B
Latest round date
September 2020
Headquarters
Boston, MA
Notable investors
Morningside Ventures, 24Haymarket, Metellus AG
Frequently asked about Immune Regulation funding
How much has Immune Regulation raised?
Immune Regulation has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Immune Regulation?
Morningside Ventures, 24Haymarket, Metellus AG are named among the investors backing Immune Regulation.
What was the latest Immune Regulation funding round?
The most recent disclosed round is a Series B, announced in September 2020.
Where is Immune Regulation based?
Immune Regulation is based in Boston, MA.
When did Immune Regulation last raise?
The last disclosed Immune Regulation round closed in September 2020 at Series B.
Totals shown for Immune Regulation aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
